Association of a Large Panel of Cytokine Gene Polymorphisms with Complications and Comorbidities in Type 2 Diabetes Patients

Table 3

Clinical and laboratorial characteristics in T2D patients considering neuropathy (DNR).

Variables	Diabetic neuropathy
	Yes ()	No ()
Age (years)	58.00 (12.00)	53.50 (15.00)	0.012
Gender (male/female) %	4.76/95.24	28.33/71.67	0.003
BMI (Kg/m^2)	30.89 ± 5.79	33.84 ± 7.87	0.356
Hypertension (yes/no) %	90.48/9.52	93.33/6.67	0.714
Dyslipidemia (yes/no) %	100.00/0	90.00/10.00	0.079
Fasting glucose (mg/dL)	145.00 (95.00)	125.50 (68.00)	0.711
Postprandial glucose (mg/dL)	226.00 (100.00)	185.00 (107.25)	0.195
HbA1c %	9.22 ± 2.04	8.71 ± 1.90	0.969
T2D onset (years) %
≤5	15.00	23.73	0.471
5–10	12.50	15.25
≥10	72.50	61.02

BMI: body mass index and HbA1c: glycated hemoglobin.
Normal variables (BMI and HbA1c): the data are shown as mean ± standard deviation.
No normal variables (age, fasting glucose, and postprandial glucose): the data are shown as median (interquartile range).
Categorical variables (gender, hypertension, dyslipidemia, and T2D onset): the data are shown as “percentage of total.”
was considered statistically significant.